Synthetic biology for therapeutic applications

Molecular Pharmaceutics

Volumn 12, Issue 2, 2015, Pages 322-331

  Abil, Zhanar ^a   Xiong, Xiong ^b   Zhao, Huimin ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c University of Illinois at Urbana Champaign   (United States)

Author keywords

cancer treatment; disease mechanism; drug discovery; infectious diseases; metabolic disorders; synthetic biology; therapeutic treatment; vaccine development

Indexed keywords

ENDONUCLEASE;

BACTERIAL INFECTION; BACTERIOPHAGE; COMMENSAL; DRUG DEVELOPMENT; IMMUNOPATHOLOGY; METABOLIC DISORDER; NONHUMAN; ONCOLYTIC VIROTHERAPY; OPTOGENETICS; PRIORITY JOURNAL; REVIEW; SYNTHETIC BIOLOGY; VACCINATION; VIRUS INFECTION; ANIMAL; HUMAN; PROCEDURES;

ANIMALS; DRUG DISCOVERY; HUMANS; SYNTHETIC BIOLOGY;

EID: 84961288305     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500392q     Document Type: Review

References (79)

1. Gardner, T. S.; Cantor, C. R.; Collins, J. J. Construction of a genetic toggle switch in Escherichia coli Nature 2000, 403, 339-42
2. Elowitz, M. B.; Leibler, S. A synthetic oscillatory network of transcriptional regulators Nature 2000, 403, 335-8
3. You, L.; Cox, R. S., III; Weiss, R.; Arnold, F. H. Programmed population control by cell-cell communication and regulated killing Nature 2004, 428, 868-71
4. Fung, E.; Wong, W. W.; Suen, J. K.; Bulter, T.; Lee, S. G.; Liao, J. C. A synthetic gene-metabolic oscillator Nature 2005, 435, 118-22
5. Rinaudo, K.; Bleris, L.; Maddamsetti, R.; Subramanian, S.; Weiss, R.; Benenson, Y. A universal RNAi-based logic evaluator that operates in mammalian cells Nature Biotechnol. 2007, 25, 795-801
6. Tabor, J. J.; Salis, H. M.; Simpson, Z. B.; Chevalier, A. A.; Levskaya, A.; Marcotte, E. M.; Voigt, C. A.; Ellington, A. D. A synthetic genetic edge detection program Cell 2009, 137, 1272-81
7. Friedland, A. E.; Lu, T. K.; Wang, X.; Shi, D.; Church, G.; Collins, J. J. Synthetic gene networks that count Science 2009, 324, 1199-202
8. Ellis, T.; Wang, X.; Collins, J. J. Diversity-based, model-guided construction of synthetic gene networks with predicted functions Nat. Biotechnol. 2009, 27, 465-71
9. Danino, T.; Mondragon-Palomino, O.; Tsimring, L.; Hasty, J. A synchronized quorum of genetic clocks Nature 2010, 463, 326-30
10. Bassetti, M.; Merelli, M.; Temperoni, C.; Astilean, A. New antibiotics for bad bugs: where are we? Ann. Clin. Microbiol. Antimicrob. 2013, 12, 22
11. Jones, K. E.; Patel, N. G.; Levy, M. A.; Storeygard, A.; Balk, D.; Gittleman, J. L.; Daszak, P. Global trends in emerging infectious diseases Nature 2008, 451, 990-3
12. Holohan, C.; Van Schaeybroeck, S.; Longley, D. B.; Johnston, P. G. Cancer drug resistance: an evolving paradigm Nat. Rev. Cancer 2013, 13, 714-26
13. Pritchard, J. R.; Lauffenburger, D. A.; Hemann, M. T. Understanding resistance to combination chemotherapy Drug Resist. Updates 2012, 15, 249-57
14. Ferrari, S.; Lougaris, V.; Caraffi, S.; Zuntini, R.; Yang, J.; Soresina, A.; Meini, A.; Cazzola, G.; Rossi, C.; Reth, M.; Plebani, A. Mutations of the Igbeta gene cause agammaglobulinemia in man J. Exp. Med. 2007, 204, 2047-51
15. Larman, H. B.; Zhao, Z.; Laserson, U.; Li, M. Z.; Ciccia, A.; Gakidis, M. A.; Church, G. M.; Kesari, S.; Leproust, E. M.; Solimini, N. L.; Elledge, S. J. Autoantigen discovery with a synthetic human peptidome Nat. Biotechnol. 2011, 29, 535-41
16. Cai, M.; Yang, Y. Targeted genome editing tools for disease modeling and gene therapy Curr. Gene Ther. 2014, 14, 2-9
17. Gaj, T.; Gersbach, C. A.; Barbas, C. F., III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering Trends Biotechnol. 2013, 31, 397-405
18. Pan, Y.; Xiao, L.; Li, A. S.; Zhang, X.; Sirois, P.; Zhang, J.; Li, K. Biological and biomedical applications of engineered nucleases Mol. Biotechnol. 2013, 55, 54-62
19. Nyquist, M. D.; Li, Y.; Hwang, T. H.; Manlove, L. S.; Vessella, R. L.; Silverstein, K. A.; Voytas, D. F.; Dehm, S. M. TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 17492-7
20. Piganeau, M.; Ghezraoui, H.; De Cian, A.; Guittat, L.; Tomishima, M.; Perrouault, L.; Rene, O.; Katibah, G. E.; Zhang, L.; Holmes, M. C.; Doyon, Y.; Concordet, J. P.; Giovannangeli, C.; Jasin, M.; Brunet, E. Cancer translocations in human cells induced by zinc finger and TALE nucleases Genome Res. 2013, 23, 1182-93
21. Shalem, O.; Sanjana, N. E.; Hartenian, E.; Shi, X.; Scott, D. A.; Mikkelsen, T. S.; Heckl, D.; Ebert, B. L.; Root, D. E.; Doench, J. G.; Zhang, F. Genome-scale CRISPR-Cas9 knockout screening in human cells Science 2014, 343, 84-7
22. Wang, T.; Wei, J. J.; Sabatini, D. M.; Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system Science 2014, 343, 80-4
23. Weber, W.; Schoenmakers, R.; Keller, B.; Gitzinger, M.; Grau, T.; Daoud-El Baba, M.; Sander, P.; Fussenegger, M. A synthetic mammalian gene circuit reveals antituberculosis compounds Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 9994-8
24. Gonzalez-Nicolini, V.; Fux, C.; Fussenegger, M. A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells Invest. New Drugs 2004, 22, 253-62
25. Baker, D. D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery Nat. Prod. Rep. 2007, 24, 1225-44
26. Lee, S. Y.; Kim, H. U.; Park, J. H.; Park, J. M.; Kim, T. Y. Metabolic engineering of microorganisms: general strategies and drug production Drug Discovery Today 2009, 14, 78-88
27. Mora-Pale, M.; Sanchez-Rodriguez, S. P.; Linhardt, R. J.; Dordick, J. S.; Koffas, M. A. Biochemical strategies for enhancing the in vivo production of natural products with pharmaceutical potential Curr. Opin. Biotechnol. 2014, 25, 86-94
28. Keasling, J. D. Manufacturing molecules through metabolic engineering Science 2010, 330, 1355-8
29. Ajikumar, P. K.; Xiao, W. H.; Tyo, K. E.; Wang, Y.; Simeon, F.; Leonard, E.; Mucha, O.; Phon, T. H.; Pfeifer, B.; Stephanopoulos, G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli Science 2010, 330, 70-4
30. Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Ellens, K. W.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Hepp, M.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhang, Y.; Zhao, L.; Lievense, J.; Covello, P. S.; Keasling, J. D.; Reiling, K. K.; Renninger, N. S.; Newman, J. D. High-level semi-synthetic production of the potent antimalarial artemisinin Nature 2013, 496, 528-32
31. Rischer, H.; Hakkinen, S. T.; Ritala, A.; Seppanen-Laakso, T.; Miralpeix, B.; Capell, T.; Christou, P.; Oksman-Caldentey, K. M. Plant cells as pharmaceutical factories Curr. Pharm. Des. 2013, 19, 5640-60
32. Guillon, S.; Tremouillaux-Guiller, J.; Pati, P. K.; Rideau, M.; Gantet, P. Harnessing the potential of hairy roots: dawn of a new era Trends Biotechnol. 2006, 24, 403-9
33. Kai, G.; Xu, H.; Zhou, C.; Liao, P.; Xiao, J.; Luo, X.; You, L.; Zhang, L. Metabolic engineering tanshinone biosynthetic pathway in Salvia miltiorrhiza hairy root cultures Metab. Eng. 2011, 13, 319-27
34. Giudice, E. L.; Campbell, J. D. Needle-free vaccine delivery Adv. Drug Delivery Rev. 2006, 58, 68-89
35. Streatfield, S. J. Delivery of plant-derived vaccines Expert Opin. Drug Delivery 2005, 2, 719-28
36. Dreesen, I. A.; Charpin-El Hamri, G.; Fussenegger, M. Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection J. Biotechnol. 2010, 145, 273-80
37. Ardiani, A.; Higgins, J. P.; Hodge, J. W. Vaccines based on whole recombinant Saccharomyces cerevisiae cells FEMS Yeast Res. 2010, 10, 1060-9
38. Remondo, C.; Cereda, V.; Mostbock, S.; Sabzevari, H.; Franzusoff, A.; Schlom, J.; Tsang, K. Y. Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen Vaccine 2009, 27, 987-94
39. Coleman, J. R.; Papamichail, D.; Skiena, S.; Futcher, B.; Wimmer, E.; Mueller, S. Virus attenuation by genome-scale changes in codon pair bias Science 2008, 320, 1784-7
40. Henry, M.; Debarbieux, L. Tools from viruses: bacteriophage successes and beyond Virology 2012, 434, 151-61
41. Lu, T. K.; Collins, J. J. Dispersing biofilms with engineered enzymatic bacteriophage Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 11197-202
42. Lu, T. K.; Collins, J. J. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 4629-34
43. Bhattarai, S. R.; Yoo, S. Y.; Lee, S. W.; Dean, D. Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection Biomaterials 2012, 33, 5166-74
44. Duan, F.; March, J. C. Interrupting Vibrio cholerae infection of human epithelial cells with engineered commensal bacterial signaling Biotechnol. Bioeng. 2008, 101, 128-34
45. Duan, F.; March, J. C. Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 11260-4
46. Gomaa, A. A.; Klumpe, H. E.; Luo, M. L.; Selle, K.; Barrangou, R.; Beisel, C. L. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems mBio 2013, 5, e00928-13
47. Perez, E. E.; Wang, J.; Miller, J. C.; Jouvenot, Y.; Kim, K. A.; Liu, O.; Wang, N.; Lee, G.; Bartsevich, V. V.; Lee, Y. L.; Guschin, D. Y.; Rupniewski, I.; Waite, A. J.; Carpenito, C.; Carroll, R. G.; Orange, J. S.; Urnov, F. D.; Rebar, E. J.; Ando, D.; Gregory, P. D.; Riley, J. L.; Holmes, M. C.; June, C. H. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases Nat. Biotechnol. 2008, 26, 808-16
48. Bloom, K.; Ely, A.; Mussolino, C.; Cathomen, T.; Arbuthnot, P. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases Mol. Ther. 2013, 21, 1889-97
49. Ebina, H.; Misawa, N.; Kanemura, Y.; Koyanagi, Y. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus Sci. Rep. 2013, 3, 2510
50. Sze, D. Y.; Reid, T. R.; Rose, S. C. Oncolytic virotherapy J. Vasc. Interventional Radiol. 2013, 24, 1115-22
51. Miest, T. S.; Cattaneo, R. New viruses for cancer therapy: meeting clinical needs Nat. Rev. Microbiol. 2014, 12, 23-34
52. Verheije, M. H.; Rottier, P. J. Retargeting of viruses to generate oncolytic agents Adv. Virol. 2012, 2012, 798526
53. Friedrich, K.; Hanauer, J. R.; Prufer, S.; Munch, R. C.; Volker, I.; Filippis, C.; Jost, C.; Hanschmann, K. M.; Cattaneo, R.; Peng, K. W.; Pluckthun, A.; Buchholz, C. J.; Cichutek, K.; Muhlebach, M. D. DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety Mol. Ther. 2013, 21, 849-59
54. Kaluza, K. M.; Kottke, T.; Diaz, R. M.; Rommelfanger, D.; Thompson, J.; Vile, R. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape Hum. Gene Ther. 2012, 23, 1054-64
55. Cerullo, V.; Pesonen, S.; Diaconu, I.; Escutenaire, S.; Arstila, P. T.; Ugolini, M.; Nokisalmi, P.; Raki, M.; Laasonen, L.; Sarkioja, M.; Rajecki, M.; Kangasniemi, L.; Guse, K.; Helminen, A.; Ahtiainen, L.; Ristimaki, A.; Raisanen-Sokolowski, A.; Haavisto, E.; Oksanen, M.; Karli, E.; Karioja-Kallio, A.; Holm, S. L.; Kouri, M.; Joensuu, T.; Kanerva, A.; Hemminki, A. Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients Cancer Res. 2010, 70, 4297-309
56. Forbes, N. S. Engineering the perfect (bacterial) cancer therapy Nat. Rev. Cancer 2010, 10, 785-94
57. Massa, P. E.; Paniccia, A.; Monegal, A.; de Marco, A.; Rescigno, M. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas Blood 2013, 122, 705-14
58. Pedrazzoli, P.; Comoli, P.; Montagna, D.; Demirer, T.; Bregni, M.; Ebmt, S. Is adoptive T-cell therapy for solid tumors coming of age? Bone Marrow Transplant. 2012, 47, 1013-9
59. Han, E. Q.; Li, X. L.; Wang, C. R.; Li, T. F.; Han, S. Y. Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges J. Hematol. Oncol. 2013, 6, 47
60. Chmielewski, M.; Hombach, A. A.; Abken, H. Antigen-specific T-cell activation independently of the MHC: Chimeric antigen receptor-redirected T cells Front. Immunol. 2013, 4, 371
61. Sadelain, M.; Brentjens, R.; Riviere, I. The promise and potential pitfalls of chimeric antigen receptors Curr. Opin. Immunol. 2009, 21, 215-23
62. Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; Olszewska, M.; Bernal, Y.; Pegram, H.; Przybylowski, M.; Hollyman, D.; Usachenko, Y.; Pirraglia, D.; Hosey, J.; Santos, E.; Halton, E.; Maslak, P.; Scheinberg, D.; Jurcic, J.; Heaney, M.; Heller, G.; Frattini, M.; Sadelain, M. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias Blood 2011, 118, 4817-28
63. Porter, D. L.; Levine, B. L.; Kalos, M.; Bagg, A.; June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia N. Engl. J. Med. 2011, 365, 725-33
64. Savoldo, B.; Ramos, C. A.; Liu, E.; Mims, M. P.; Keating, M. J.; Carrum, G.; Kamble, R. T.; Bollard, C. M.; Gee, A. P.; Mei, Z.; Liu, H.; Grilley, B.; Rooney, C. M.; Heslop, H. E.; Brenner, M. K.; Dotti, G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients J. Clin. Invest. 2011, 121, 1822-6
65. Tammana, S.; Huang, X.; Wong, M.; Milone, M. C.; Ma, L.; Levine, B. L.; June, C. H.; Wagner, J. E.; Blazar, B. R.; Zhou, X. 4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies Hum. Gene Ther. 2010, 21, 75-86
66. Kloss, C. C.; Condomines, M.; Cartellieri, M.; Bachmann, M.; Sadelain, M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells Nat. Biotechnol. 2013, 31, 71-5
67. Lanitis, E.; Poussin, M.; Klattenhoff, A. W.; Song, D.; Sandaltzopoulos, R.; June, C. H.; Powell, D. J. Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused anti-tumor activity with reduced potential for toxicity Cancer immunology research 2013, 10.1158/2326-6066.CIR-13-0008
68. Schwenk, R. W.; Vogel, H.; Schurmann, A. Genetic and epigenetic control of metabolic health Mol. Metab. 2013, 2, 337-347
69. Duan, F.; Curtis, K. L.; March, J. C. Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes Appl. Environ. Microbiol. 2008, 74, 7437-8
70. Ye, H.; Aubel, D.; Fussenegger, M. Synthetic mammalian gene circuits for biomedical applications Curr. Opin. Chem. Biol. 2013, 17, 910-7
71. Lienert, F.; Lohmueller, J. J.; Garg, A.; Silver, P. A. Synthetic biology in mammalian cells: next generation research tools and therapeutics Nat. Rev. Mol. Cell Biol. 2014, 15, 95-107
72. Karlsson, M.; Weber, W. Therapeutic synthetic gene networks Curr. Opin. Biotechnol. 2012, 23, 703-11
73. Ye, H.; Charpin-El Hamri, G.; Zwicky, K.; Christen, M.; Folcher, M.; Fussenegger, M. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 141-6
74. Kemmer, C.; Gitzinger, M.; Daoud-El Baba, M.; Djonov, V.; Stelling, J.; Fussenegger, M. Self-sufficient control of urate homeostasis in mice by a synthetic circuit Nat. Biotechnol. 2010, 28, 355-60
75. Rossger, K.; Charpin-El-Hamri, G.; Fussenegger, M. A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice Nat. Commun. 2013, 4, 2825
76. Ye, H.; Daoud-El Baba, M.; Peng, R. W.; Fussenegger, M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice Science 2011, 332, 1565-8
77. Stanley, S. A.; Gagner, J. E.; Damanpour, S.; Yoshida, M.; Dordick, J. S.; Friedman, J. M. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice Science 2012, 336, 604-8
78. Yu, T.; Bao, X.; Piao, W.; Peng, J.; Li, W.; Yang, C.; Xing, M.; Zhang, Y.; Qi, J.; Xu, L.; Xu, L.; Liu, Q. Recent patents on oligonucleotide synthesis and gene synthesis Recent Pat. DNA Gene Sequences 2012, 6, 10-21
79. Smolke, C. D. Building outside of the box: iGEM and the BioBricks Foundation Nat. Biotechnol. 2009, 27, 1099-102